January 1, 2005Health Affairs
Evidence-Based Medicine And Policy: The Case Of The Implantable Cardioverter Defibrillator
Key result
The implantable cardioverter defibrillator presents a challenge to evidence-based medicine and policymakers due to its high cost, large eligible population, and unsettled state of medical evidence.
Population
Patients at high risk of sudden cardiac death
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Unsettled ICD evidence hinders coverage decisions; leaves open optimal patient selection for clinicians and researchers.
Structured PICO
P
Population
Patients at high risk of sudden cardiac death
I
Intervention
Implantable cardioverter defibrillator (ICD)
Highlights the tension between ongoing clinical trials and the immediate need for policy decisions regarding insurance coverage for costly ICD therapies.
Cite This Study
Hlatky et al. (2005) conducted a review in High risk of sudden cardiac death. Implantable cardioverter defibrillator (ICD) was evaluated. The implantable cardioverter defibrillator presents a challenge to evidence-based medicine and policymakers due to its high cost, large eligible population, and unsettled state of medical evidence.